b'Our Community Innovatorson the RiseOur campus is home to more than 80 visionary organizations and 800 employees in pharmaceuticals, cell and gene therapy, medical devices, molecular biology, diagnostics, and more. These companies are collaborating, thriving, and making major discoveries and advancements in health and care. And theyre all doing it right here.Colorado Prevention Center GelSana(CPC) Clinical Research Making a Material Impact on Advancing Wound Care Transforming Clinical TrialsGelSana engineers highly elastic wound dressing polymers Founded over 35 years ago, the Colorado Prevention Centerwhich stretch and conform across any wound, reduce (CPC) is a non-profit academic research and communityinflammation through polymer chemistry, prevent infection, health organization affiliated with the University of Coloradoand provide sustained drug delivery over time.School of Medicine. Over 120 staff and faculty membersGelSana is bringing an entirely new class of materials to the are dedicated to the mission of improving health throughwound care field to truly make a significant advancement in innovative science and community engagement and towound care technology, improving outcomes and quality of realize the vision of being a global leader in research andlife for patients around the world. healthcare implementation. Currently, CPC is conducting several global pivotal clinical trials in cardiometabolicMelissa Krebs, Ph.D., CEO, and Founder, GelSanadisease, vascular disease, and prevention with a goal of implementing innovations in our local communities throughREAD SPOTLIGHTtheir long-standing community health programs.READ SPOTLIGHTLohocla ResearchTransforming Lives for Sufferers of Chronic Pain, Neurodegenerative Disease, and Addictive Disorders EnteroTrack Lohocla Research Corporation conceptualizes novel Empowering Patients to Take Control of Chronicsolutions for difficult medical problems like chronic pain, Upper Gastointestinal (GI) Healthneurodegenerative disease, and addictive disorders by employing an iconoclastic approach. Deep experience EnteroTrack produces EnteroTracker, a simple-to-use,undergirds the scientific expertise of the companys executive inexpensive device to sample the upper GI system in childrenscientists. To date, Lohocla Research has brought two and adults without the need for endoscopy. Screening orfirst-in-class small-molecule drugs to first-in-human trials: monitoring the upper GI tract is important to catch diseasesKindolor and Nezavist.early such as esophageal cancer or to control chronic conditions such as Eosinophilic Esophagitis (EoE).Lohocla Research is a compassionate company dedicated to improving quality of life. We understand the significant For the 100 million Americans living with or at risk forchallenges associated with chronic pain, neuroinflammatory chronic upper GI diseases, the EnteroTracker shows promisedisease, and addiction, and we focus on transforming the lives for revolutionizing and democratizing upper GI medical care. of patients suffering from these conditions. Robin Shandas, Ph.D., CEO, EnteroTrack Boris Tabakoff, Ph.D., CEO, and Founder,Lohocla Research CorporationREAD SPOTLIGHT READ SPOTLIGHT16Fitzsimons Innovation Community 2024 Annual Innovation Report'